drug · antibody
imeroprubart
Phase 3updated 5mo agoby $IMVT Immunovant, Inc.🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Unknown, with 1 investigational indication.
indications
indications
Rheumatoid Arthritis
all catalysts(0)
nothing on the calendar yet
Trials studying imeroprubart
News(3)
- 6 immunology targets to sustain a mammoth I&I marketJohnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and…biospace · 6d ago
- Immunovant ditches lupus for multi-hyphenate inflammatory drug after mid-stage missAfter imeroprubart failed to demonstrate sufficient efficacy in lupus during a Phase 2b trial, Immunovant is moving on from the indication and looking to other high priority programs for the drug i…biospace · 11d ago
- Roivant reports Phase 2b lupus failure for an FcRn drugOne of Roivant’s leading autoimmune pipeline candidates failed a Phase 2b study in a form of lupus, the company said Wednesday morning. The program, known as IMVT-1402 or imeroprubart, did not impr…endpoints · 11d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that